DrugPatentWatch Database Preview
CARDURA Drug Profile
Email this page to a colleague
» See Plans and PricingWhich patents cover Cardura, and when can generic versions of Cardura launch?
Cardura is a drug marketed by Pfizer and is included in two NDAs.
The generic ingredient in CARDURA is doxazosin mesylate. There are fourteen drug master file entries for this compound. Twenty-eight suppliers are listed for this compound. Additional details are available on the doxazosin mesylate profile page.
US ANDA Litigation and Generic Entry Outlook for Cardura
A generic version of CARDURA was approved as doxazosin mesylate by APOTEX on October 18th, 2000.
Summary for CARDURA
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 2 |
| Suppliers / Packagers: | 2 |
| Bulk Api Vendors: | 84 |
| Clinical Trials: | 10 |
| Patent Applications: | 1,552 |
| Formulation / Manufacturing: | see details |
| Drug Prices: | Drug price information for CARDURA |
| DailyMed Link: | CARDURA at DailyMed |
Pharmacology for CARDURA
| Drug Class | alpha-Adrenergic Blocker |
| Mechanism of Action | Adrenergic alpha-Antagonists |
Paragraph IV (Patent) Challenges for CARDURA
| Tradename | Dosage | Ingredient | NDA | Submissiondate |
|---|---|---|---|---|
| CARDURA | TABLET;ORAL | doxazosin mesylate | 019668 |
US Patents and Regulatory Information for CARDURA
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Pfizer | CARDURA | doxazosin mesylate | TABLET;ORAL | 019668-001 | Nov 2, 1990 | AB | RX | Yes | Yes | Start Trial | Start Trial | Start Trial | |||
| Pfizer | CARDURA | doxazosin mesylate | TABLET;ORAL | 019668-004 | Nov 2, 1990 | AB | RX | Yes | No | Start Trial | Start Trial | Start Trial | |||
| Pfizer | CARDURA | doxazosin mesylate | TABLET;ORAL | 019668-002 | Nov 2, 1990 | AB | RX | Yes | No | Start Trial | Start Trial | Start Trial | |||
| Pfizer | CARDURA | doxazosin mesylate | TABLET;ORAL | 019668-003 | Nov 2, 1990 | AB | RX | Yes | No | Start Trial | Start Trial | Start Trial | |||
| Pfizer | CARDURA XL | doxazosin mesylate | TABLET, EXTENDED RELEASE;ORAL | 021269-002 | Feb 22, 2005 | RX | Yes | Yes | Start Trial | Start Trial | Start Trial | ||||
| Pfizer | CARDURA XL | doxazosin mesylate | TABLET, EXTENDED RELEASE;ORAL | 021269-001 | Feb 22, 2005 | RX | Yes | No | Start Trial | Start Trial | Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for CARDURA
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Pfizer | CARDURA | doxazosin mesylate | TABLET;ORAL | 019668-001 | Nov 2, 1990 | Start Trial | Start Trial |
| Pfizer | CARDURA | doxazosin mesylate | TABLET;ORAL | 019668-003 | Nov 2, 1990 | Start Trial | Start Trial |
| Pfizer | CARDURA | doxazosin mesylate | TABLET;ORAL | 019668-002 | Nov 2, 1990 | Start Trial | Start Trial |
| Pfizer | CARDURA | doxazosin mesylate | TABLET;ORAL | 019668-004 | Nov 2, 1990 | Start Trial | Start Trial |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for CARDURA
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Austria | A28881 | Start Trial |
| Spain | 474805 | Start Trial |
| Croatia | P931466 | Start Trial |
| Poland | 119586 | Start Trial |
| Finland | 783347 | Start Trial |
| Austria | 366684 | Start Trial |
| Luxembourg | 80470 | Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
